Lensar/$LNSR
1D1W1MYTD1Y5YMAX
About Lensar
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
- Ticker
- $LNSR
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 150
- Headquarters
- Orlando, United States
- Website
- www.lensar.com
Lensar Metrics
BasicAdvanced
$104M
15.94
$0.53
0.88
-
Price and volume
Market cap
$104M
Beta
0.88
52-week high
$12.94
52-week low
$4.95
Average daily volume
153K
Financial strength
Current ratio
2.394
Quick ratio
1.005
Long term debt to equity
5.539
Total debt to equity
8.299
Interest coverage (TTM)
-55.55%
Profitability
EBITDA (TTM)
-16.328
Gross margin (TTM)
48.34%
Net profit margin (TTM)
57.57%
Operating margin (TTM)
-34.68%
Revenue per employee (TTM)
$400,000
Management effectiveness
Return on assets (TTM)
-11.16%
Return on equity (TTM)
357.30%
Valuation
Price to earnings (TTM)
15.94
Price to revenue (TTM)
1.705
Price to book
6.97
Price to tangible book (TTM)
10.22
Price to free cash flow (TTM)
-14.021
Free cash flow yield (TTM)
-7.13%
Free cash flow per share (TTM)
-0.603
Growth
Revenue change (TTM)
3.26%
Earnings per share change (TTM)
-112.62%
3-year revenue growth (CAGR)
16.37%
3-year earnings per share growth (CAGR)
-32.74%
Lensar News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.